Results 61 to 70 of about 194 (96)
ADVANCE OF TOXICOGENETIC CONSIDERATIONS ON THE NEW DRUG DEVELOPEMENT
openaire +2 more sources
Forthcoming Toxicogenetic Studies in the New Drug Development.
openaire +2 more sources
Toxicogenetics-Pharmacogenetics: Genetic variability profiling for xenobiotic response heterogeneity
Drakoulis, N., Papasavva, M.
core
Kernel Multitask Regression for Toxicogenetics [PDF]
Abstract The development of high-throughput in vitro assays to study quantitatively the toxicity of chemical compounds on genetically characterized human-derived cell lines paves the way to predictive toxicogenetics , where one would be able to ...
Thomas Walter +2 more
exaly +7 more sources
Toxicogenetics: Applications and Opportunities. [PDF]
The response to drugs and environmental chemicals varies with genotype. Some patients react well to drugs, while others may not benefit, or may even respond adversely. Individuals also experience different reactions to environmental agents, such as allergens.
Ian Kimber, George Orphanides
exaly +4 more sources
Toxicogenetics in Drug Development
The major progress made in the understanding of the genetic basis of inter-individual variation in drug response, alongside the rapid advances in technology, provides major new opportunities to ensure the safe introduction of a new chemical entity into clinical practice.
Brian Kevin Park, Munir Pirmohamed
exaly +4 more sources
Toxicogenetics of Antiretroviral Therapy: Genetic Factors That Contribute to Metabolic Complications
Metabolic complications of antiretroviral therapy (ART) have emerged as a major concern for long-term, successful management of HIV infection. Variability in the response to ART between individuals has been increasingly linked to the genetic background of patients, as regards efficacy and susceptibility to adverse reactions (toxicogenetics).
Amalio Telenti, Philip E Tarr
exaly +5 more sources
Toxicogenetics of Lopinavir/Ritonavir in Hiv-Infected European Patients
We present a genetic association study in 106 European HIV-infected individuals aimed at identifying and confirming polymorphisms that have a significant influence on toxicity derived from treatment with lopinavir/ritonavir (LPV/r).Genotyping was performed by matrix-assisted laser desorption/ionization-time of flight and KASPar® (KBiosciences ...
Raquel Cruz +2 more
exaly +7 more sources

